INDmoney
C4 Therapeutics, Inc Stock Performance
as on January 29, 2026 at 2:29 am IST
Day's Low
Day's High
$2.00$2.14
1.96%
Downside
4.90%
Upside
52 Week's Low
52 Week's High
$1.09$3.8446.81%
Downside
88.24%
Upside
C4 Therapeutics, Inc share price movements today
- Previous Close
- $2.14
- Open
- $2.14
- Volume
- 1.3M
- Day's Low - High
- $2.00 - $2.14
- 52 Week Low - High
- $1.09 - $3.84
C4 Therapeutics, Inc Historical Returns
- 1 Month Return
- 0 %
- 3 Month Return
- -19.12 %
- 1 Year Return
- -43.45 %
- 3 Year Return
- -74.11 %
- 5 Year Return
- -94.38 %
C4 Therapeutics, Inc Stock Fundamentals & Key Indicators
Check C4 Therapeutics, Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$200.6M
EPS (TTM)
-1.52
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-4.13
Industry PE ratio
-2.8252449567723343
PEG Ratio
0EBITDA
-117.0M
Revenue (TTM)
30.1M
Profit Margin
0.00%
Return On Equity TTM
-59.98%
C4 Therapeutics, Inc Stock Valuation
Track how C4 Therapeutics, Inc P/E has moved over time to understand its valuation trends.
C4 Therapeutics, Inc in the last 5 years
Lowest (-27.63x)
September 30, 2021
Today (-4.13x)
January 29, 2026
Industry (-2.83x)
January 29, 2026
Highest (-0.86x)
December 31, 2023
Today’s Price to Earnings Ratio: -4.13x
C4 Therapeutics, Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of C4 Therapeutics, Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $200.6M | -94.38% | -4.13 | 0.00% | |
| BUY | $47.7B | 132.31% | 1246.03 | 1.36% | |
| BUY | $122.3B | 108.62% | 33.56 | 31.35% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 49.08% | 18.28 | 32.13% |
Stock Returns calculator for C4 Therapeutics, Inc Stock including INR - Dollar returns
The C4 Therapeutics, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
C4 Therapeutics, Inc investment value today
Current value as on today
₹62,799
Returns
Returns from C4 Therapeutics, Inc Stock
Dollar Returns*
₹5,974 (+5.97%)
Analyst Recommendation on C4 Therapeutics, Inc Stock
Based on 15 analysts
73.33%
Buy
26.67%
Hold
0.00%
Sell
Based on 15 analysts, 73.33% of analysts recommend a 'BUY' rating for C4 Therapeutics, Inc. Average target price of $9.86
C4 Therapeutics, Inc Share Price Target
Get share price movements and forecasts by analysts on C4 Therapeutics, Inc.
What analysts predicted
79.31%UPSIDE
Target Price
$9.86
Current Price
$2.04
Analyzed by
15 Analysts
Target
$9.86
C4 Therapeutics, Inc target price $9.86, a slight upside of 79.31% compared to current price of $2.04. According to 15 analysts rating.
C4 Therapeutics, Inc Stock’s Investor Sentiment and Interest
Search interest for C4 Therapeutics, Inc Stock has increased by 26% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:26% versus previous 30 day period
C4 Therapeutics, Inc Quarterly Profit & Loss
All numbers in Millions USD
C4 Therapeutics, Inc Annual Profit & Loss
All numbers in Millions USD
C4 Therapeutics, Inc Quarterly Cash Flow
All numbers in Millions USD
C4 Therapeutics, Inc Annual Cash Flow
All numbers in Millions USD
Insights on C4 Therapeutics, Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 6.46M → 11.23M (in $), with an average increase of 42.5% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 34.7% return, outperforming this stock by 108.8%
- NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 54.4% return, outperforming this stock by 97.9%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 2 quarters, -26.02M → -32.16M (in $), with an average decrease of 23.6% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 7 days, CCCC stock has moved down by -6.9%
About C4 Therapeutics, Inc
| Organisation | C4 Therapeutics, Inc |
| Headquarters | 490 Arsenal Way, Watertown, MA, United States, 02472 |
| Industry | Health Technology |
| CEO | Mr. Andrew J. Hirsch M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of C4 Therapeutics, Inc
Name | Title |
|---|---|
Ms. Kendra Adams | Chief Financial Officer and Head of Corporate Affairs & Treasurer |
Dr. Leonard M. J. Reyno M.D. | Chief Medical Officer |
Dr. Nathanael S. Gray Ph.D. | Co-Founder & Member of Scientific Advisory Board |
Ms. Paige Mahaney Ph.D. | Chief Scientific Officer |
Ms. Courtney Solberg | Senior Manager of Investor Relations |
Ms. Kelly A. Schick | Chief People Officer |
Mr. Andrew J. Hirsch M.B.A. | CEO, President & Director |
Dr. Kenneth C. Anderson M.D., Ph.D. | Co-Founder, Independent Director & Member of Scientific Advisory Board |
Mr. Mark Mossler | Chief Accounting Officer |
Dr. Isabel Chiu Ph.D. | Senior Vice President of Strategic Alliances & Business Development |
FAQs
What is C4 Therapeutics, Inc share price today?
C4 Therapeutics, Inc share price today is $2.04 as on at the close of the market. C4 Therapeutics, Inc share today touched a day high of $2.14 and a low of $2.
What is the 52 week high and 52 week low for C4 Therapeutics, Inc share?
C4 Therapeutics, Inc share touched a 52 week high of $3.84 on and a 52 week low of $1.09 on . C4 Therapeutics, Inc stock price today i.e. is closed at $2.04,which is 46.87% down from its 52 week high and 88.02% up from its 52 week low.
What is C4 Therapeutics, Inc's market capitalisation today?
C4 Therapeutics, Inc market capitalisation is $0.00T as on .
How to invest in C4 Therapeutics, Inc Stock (CCCC) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for C4 Therapeutics, Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in C4 Therapeutics, Inc Shares that will get you 0.7353 shares as per C4 Therapeutics, Inc share price of $2.04 per share as on January 29, 2026 at 2:29 am IST.
What is the minimum amount required to buy C4 Therapeutics, Inc Stock (CCCC) from India?
Indian investors can start investing in C4 Therapeutics, Inc (CCCC) shares with as little as ₹91.762 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹917.62 in C4 Therapeutics, Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on C4 Therapeutics, Inc share’s latest price of $2.04 as on January 29, 2026 at 2:29 am IST, you will get 4.9020 shares of C4 Therapeutics, Inc. Learn more about
fractional shares .
What are the returns that C4 Therapeutics, Inc has given to Indian investors in the last 5 years?
C4 Therapeutics, Inc stock has given -94.38% share price returns and 25.73% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?